LegalView Launches Revamped Ketek Information Portal with Details of the Drug's Potential Risks

Denver, CO - LegalView announced its newly revamped Ketek information portal, which will provide details of the antibiotic’s alleged risks. The potential ketek side effects already identified have included liver damage and liver failure, and the drug has been allegedly linked to at least 18 deaths and more than 100 cases of liver damage, according to a public safety advisory from the U.S. Food and Drug Administration (FDA) that was issued in 2006. However, the drug has not been recalled and patients who have taken the drug are advised to consider contacting a Ketek law firm, which can offer assistance in finding an experienced Ketek lawyer. A French company, Sanofi-Aventis, manufactures Ketek, also known as telithromycin. The drug treats upper respiratory infections including bronchitis, community acquired pneumonia,... [read full story]